Tenet Healthcare Corporation $THC Shares Acquired by Swedbank AB

Swedbank AB boosted its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 14.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 146,133 shares of the company’s stock after buying an additional 18,750 shares during the period. Swedbank AB’s holdings in Tenet Healthcare were worth $29,040,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. WCM Investment Management LLC increased its holdings in shares of Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after purchasing an additional 362,083 shares during the period. AlphaQuest LLC increased its holdings in shares of Tenet Healthcare by 238.3% in the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after purchasing an additional 4,202 shares during the period. Winnow Wealth LLC acquired a new position in Tenet Healthcare during the third quarter worth $1,129,000. Savant Capital LLC grew its holdings in Tenet Healthcare by 27.5% during the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after acquiring an additional 3,647 shares during the period. Finally, Caption Management LLC acquired a new position in Tenet Healthcare during the third quarter worth $5,650,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Royal Bank Of Canada dropped their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a report on Friday, May 1st. Wells Fargo & Company dropped their price objective on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Barclays dropped their price objective on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Finally, Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Nineteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Stock Performance

NYSE THC opened at $174.00 on Monday. The business’s 50-day moving average price is $194.07 and its 200 day moving average price is $202.90. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The company has a market capitalization of $14.99 billion, a PE ratio of 9.05, a price-to-earnings-growth ratio of 1.14 and a beta of 1.30. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm’s revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm posted $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, research analysts predict that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.

Insider Activity

In other news, EVP Thomas W. Arnst sold 8,000 shares of the stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $238.85, for a total value of $1,910,800.00. Following the completion of the sale, the executive vice president owned 12 shares in the company, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the transaction, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 46,517 shares of company stock worth $10,943,111. 0.97% of the stock is currently owned by corporate insiders.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.